Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04224285 · ClinicalTrials.gov registry record · NA

Operational Trial of Dayzz App

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
1,355
Enrollment target

NCT04224285 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 1,355 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04224285, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
1,355 participants
Enrollment target

Study Summary

Sleep deficiency is a hidden cost of our 24-7 society, with 70% of Americans admitting that they routinely obtain insufficient sleep, 30% of US workers report sleeping less than 6 hours per night, and it is estimated that 50-70 million individuals have a sleep disorder. Undiagnosed and untreated sleep disorders are associated with poor health outcomes for the individual and generate substantial costs for the employer. Diminished alertness resulting from sleep deficiency or undiagnosed and untreated sleep disorders contributes to absenteeism, presenteeism (diminished work performance at work), health care expenditure, occupational injuries, workplace accidents, and commute-related motor vehicle crashes; all of which result in substantial direct and indirect costs. The investigators have shown that adverse impacts on employees and employers can be mitigated through a sleep health education and sleep disorder screening program which have been implemented in a variety of industries. Further, smartphone apps are becoming popular. Dayzz has created a personalized sleep training app that evaluates sleep issues and offers a holistic sleep improvement solution. It is unique in that the sleep app uses evidence-based, big-data-based algorithms to provide personalized sleep training plans. The sleep solutions are tailored to the individual user and leverages unique motivational strategies and continuous supportive messaging. The investigators hypothesize that the Dayzz app, offering a personalized, scientifically based sleep training plan, might further promote improved health, safety and well-being. This clinical trial will implement the sleep health education and sleep disorders screening program in combination with the Dayzz app.

Interventions

  • OTHER Dayzz app

Trial Details

FieldValue
Enrollment Target 1,355 participants
Start Date 2020-08-12
Est. Completion 2021-09-30
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT04224285

The ClinicalTrials.gov registry entry for NCT04224285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,355 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dayzz app is the first listed.

NCT04224285 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04224285 about?

NCT04224285 is a clinical study titled "Operational Trial of Dayzz App". Sleep deficiency is a hidden cost of our 24-7 society, with 70% of Americans admitting that they routinely obtain insufficient sleep, 30% of US workers report sleeping less than 6 hours per night, and it is estimated that 50-70 million individuals have a sleep disorder. Undiagnosed and untreated sle...

What is the current status of trial NCT04224285?

This trial is currently completed. It is a NA study. The enrollment target is 1,355 participants. The study started on 2020-08-12. Estimated completion is 2021-09-30.

What interventions are being tested in trial NCT04224285?

The interventions under investigation include: Dayzz app (OTHER).

Who is sponsoring clinical trial NCT04224285?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.